The protein truncating mutations rs397508986 in BRCA1 and rs80358998 in BRCA2, found in the liver and pancreas samples, are components of genetic screening protocols for breast and ovarian cancer [19]. This evidence concerns the gene BRCA1 and ovarian carcinoma.